Working to Eradicate Gynecologic Cancers

Roman Yelensky, PhD

Director, Clinical Genomic Analysis
Foundation Medicine Inc.
150 Second Street
Cambridge, MA
USA 02141

Papers:
Tumor BRCA mutation or high genomic LOH identify ovarian cancer patients likely to respond to rucaparib: interim results for ARIEL2 clinical trial